{"analyses":[{"ciPctValue":"95","groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"<0.0001","statisticalMethod":"Fisher Exact","testedNonInferiority":false},{"ciPctValue":"95","groupIds":["OG001","OG002"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"<0.0001","statisticalMethod":"Fisher Exact","testedNonInferiority":false}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"91.7","upperLimit":"97.9","value":"95.5"},{"groupId":"OG001","lowerLimit":"92.5","upperLimit":"98.3","value":"96.1"},{"groupId":"OG002","lowerLimit":"0","upperLimit":"1.8","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"202"},{"groupId":"OG001","value":"207"},{"groupId":"OG002","value":"201"}],"units":"Participants"}],"description":"This outcome measure presents the testosterone levels 3 days after the initial dose of trial medication.","dispersionType":"95% Confidence Interval","groups":[{"description":"Initial dose of 240 mg SC (by injection under the skin) on day 0. Maintenance dose of 160 mg SC (by injection under the skin) given every 28 days.","id":"OG000","title":"Degarelix 240/160 mg"},{"description":"Initial dose of 240 mg SC (by injection under the skin) on day 0. Maintenance dose of 80 mg SC (by injection under the skin) given every 28 days.","id":"OG001","title":"Degarelix 240/80 mg"},{"description":"Lupron Depot 7.5 mg IM (in the muscle) every 28 days starting at day 0.","id":"OG002","title":"Leuprolide 7.5 mg"}],"paramType":"MEAN","populationDescription":"ITT population.","reportingStatus":"POSTED","timeFrame":"3 days","title":"Percentage of Patients With Testosterone Level <=0.5 ng/mL at Day 3","type":"SECONDARY","unitOfMeasure":"percentage of patients"}